Mobile-health Networkの空売り状況は、投資家がMobile-health Networkの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Mobile-health Network (NASDAQ:MNDR) 株価情報, 空売り情報

Mobile-health Network

Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services which is also its key revenue generating segment, and Sale of medicine and medical devices. Geographically, it derives revenue from Singapore.

Mobile-health Network Solutions - Class A Ordinary Shares

Mobile-health Network Solutions

News

Buybacks

REAX

Real Brokerage Board Authorizes New Share Repurchase Program For Up To Lesser Of $150M In Value, Or 35M In Shares

Quest Diagnostics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DGX#NYSE">DGX</a>) has outperformed the market over the past 5 years by 276.89% on an annualized basis producing an average annual return of 290.74%. Currently, Quest Diagnostics has a market capitalization of $19.32 billion. 
Buying $1000 In DGX: If an investor had bought $1000 of DGX stock 5 years ago, it would be worth $1,019,647.06 today based on a price of $173.07 for DGX at the time of writing.
<h3>Quest Diagnostics's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748637015_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much You Would Have Made Owning Quest Diagnostics Stock In The Last 5 Years

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/LVRLF">CordovaCann</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LVRLF#OTC">LVRLF</a>) shares closed up 22.08% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed up 19.73% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed up 13.64% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/ZDPY">Zoned Properties</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ZDPY#OTC">ZDPY</a>) shares closed up 9.67% at $0.48</li>
<li><a href="https://www.benzinga.com/quote/CLSH">CLS Holdings USA</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CLSH#OTC">CLSH</a>) shares closed up 6.06% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/ITHUF">iAnthus Capital Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTC">ITHUF</a>) shares closed up 5.77% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/SOL">Emeren Group</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) shares closed up 4.14% at $1.79</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed up 3.54% at $7.42</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed up 3.25% at $0.28</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed down 50.00% at $0.0002</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Gwth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed down 22.81% at $1.32</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed down 20.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CRLBF">Cresco Labs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>) shares closed down 11.29% at $0.60</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Global Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed down 8.49% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed down 7.15% at $0.43</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed down 5.88% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CURLF">Curaleaf Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) shares closed down 5.36% at $0.83</li>
<li><a href="https://www.benzinga.com/quote/CVSI">CV Sciences</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CVSI#OTC">CVSI</a>) shares closed down 3.27% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/SNDL">SNDL</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>) shares closed down 3.08% at $1.27</li>
<li><a href="https://www.benzinga.com/quote/TCNNF">Trulieve Cannabis</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) shares closed down 3.07% at $4.00</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cannabis

Markets

Movers

CLSH

CRBP

CRLBF

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

CVSI

FFNTF

ITHUF

LEAFBUYER TECHNOLOGIES by Leafbuyer Technologies, Inc.

LBUY

LVRLF

NWVCF

OILFF

RMHB

SNDL

SOLCF

TCNNF

TGIFF

TLRY

ZDPY

Marijuana Stock Movers For May 30, 2025

Offerings

Haoxi Health Technology Files For Mixed Shelf Of Up To $80M

A gauge tracking the so-called &#8220;magnificent seven&#8221; — which includes Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Microsoft Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NYSE">MSFT</a>), Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>). Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>), Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) and Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) — surged 15% in May.
The rally coincided with an especially solid month for U.S. equities. The S&amp;P 500, tracked by the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), surged more than 6% for the month. That&#8217;s its strongest month since November 2023.
But beneath the surface <a href="https://www.benzinga.com/general/education/25/05/45675595/apple-eyes-worst-month-vs-sp-500-since-2018-but-history-says-buy-the-dip-now#:~:text=Apple%2520underperformed%2520S%2526P%2520500%2520by,expert%2520insights%2520for%252060%2525%2520off.">is Apple's rare underperformance.</a>
Six out of the magnificent seven tech giants logged monthly gains. The iPhone maker, however, lagged its peers and delivered its weakest relative performance against the S&amp;P 500 Index since 2018.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="535" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30154913/image-426-1024x535.png" alt="" class="wp-image-933762" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30154913/image-426-1024x535.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30154913/image-426-300x157.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30154913/image-426-768x401.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30154913/image-426-1536x803.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30154913/image-426-2048x1070.png 2048w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
In contrast, Nvidia posted a staggering 24% monthly jump — its best performance since May 2024 — after delivering <a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45668727/nvidia-stock-is-surging-thursday-whats-fueling-the-move">better-than-expected quarterly earnings.</a>
Despite facing export restrictions on its chips to China, Nvidia's revenue resilience confirmed that artificial <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45675006/nvidia-stock-has-significant-upside-as-ai-godfather-jensen-huang-delivers-another-robust-quarter">intelligence demand remains healthy.</a> Overall revenue reached $44.1 billion, up 69% from a year ago.
"Countries around the world are recognizing AI as essential infrastructure — just like electricity and the internet — and Nvidia stands at the center of this profound transformation," CEO Jensen Huang said.
While Wall Street paints a positive picture, Main Street tells a different story, as pessimism among U.S. consumers runs high.
The U.S. economy contracted by 0.2% <a href="https://www.benzinga.com/government/regulations/25/05/45669445/us-economy-contracts-by-02-in-q1-labor-market-shows-signs-of-cracks-as-jobless-claims-surge">in the first quarter</a>, a slight upward revision from the initial -0.3% estimate, yet a stark reversal from the 2.4% growth rate seen in late 2024. Inflation, as measured by the <a href="https://www.benzinga.com/cannabis/25/05/45693219/feds-favorite-inflation-gauge-slows-but-trumps-china-accusation-flips-market-mood">Personal Consumption Expenditures price index</a>, cooled to 2.1% in April — its lowest pace in six months — from 2.3% in March.
But the public doesn&#8217;t seem to trust the disinflation narrative.
According to the University of Michigan's May survey, Americans expect inflation to run at 6.6% over the next year, <a href="https://www.benzinga.com/markets/economic-data/25/05/45697983/consumer-sentiment-stuck-at-3-year-lows-as-inflation-fears-hit-44-year-high">the highest level since 1981</a>. That figure reflects the widest gap ever recorded between perceived and actual inflation. Meanwhile, overall sentiment remains near three-year lows.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="535" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30155117/image-427-1024x535.png" alt="" class="wp-image-933763" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30155117/image-427-1024x535.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30155117/image-427-300x157.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30155117/image-427-768x401.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30155117/image-427-1536x803.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30155117/image-427-2048x1070.png 2048w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
In a notable development on the trade front, the U.S. Court of International Trade struck down significant portions of President Donald Trump's newly proposed tariff actions.
While the move sparked brief investor optimism, analysts caution the Trump administration retains various legal avenues to <a href="https://www.benzinga.com/government/regulations/25/05/45672421/tariffs-blocked-by-court-but-goldman-sachs-says-trump-could-reimpose-them-within-days">reintroduce similar trade barriers.</a>
Now Read:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/05/45703175/netflix-stock-could-climb-another-25-thanks-to-second-half-content-bonanza-says-bank-of-america">Netflix Stock Could Climb Another 25% Thanks To Second-Half &#8216;Content Bonanza,&#8217; Says Bank Of America </a></li>
</ul>
Image: Shutterstock

Tech

AAPL

AMZN

GOOGL

MSFT

NVDA

TSLA

Magnificent Seven Drive Wall Street's Rally, Nvidia Notches Best Month In A Year: This Week In Markets

Meta Platforms Shareholders Reject Dual Class Capital Structure Proposal

General

Eversource Energy Enters Equity Distribution Agreement With Multiple Manager; To Issue And Sell Shares Up To $1.2B

On May 29, 2025, D-Wave Quantum Inc. (the "Company") received proceeds in the aggregate amount of approximately $80.5 million in connection with the exercise of approximately 7.0 million warrants to purchase shares of the Company's common stock with an exercise price of $11.50 per warrant. These warrants were assumed by the Company in conjunction with the August 5, 2022 merger with DPCM Capital, Inc.

QBTS

D-Wave Quantum Receives ~$80.5M from Exercise Of 7M Warrants At $11.50 Each, Originating From 2022 Merger With DPCM Capital

Modiv Industrial Files For Mixed Shelf Of Up to $250M

CMDB

Costamare Bulkers Files For Mixed Shelf Of Up To $200M

On May 27, 2025, Brendon Fischer, the Interim Chief Financial Officer of Sow Good Inc. (the "Company"), informed the Company of his decision to resign, effective June 6, 2025. Mr. Fischer will assist the Company to ensure the successful transition of his responsibilities prior to his departure. His resignation is not the result of any disagreement with the Company regarding its operations, accounting or other policies or practices.

Management

SOWG

Sow Good Announces Brendon Fischer To Resign As Interim CFO, Effective June 6, 2025

RVPH

Reviva Pharmaceuticals  Enters Into At Market Issuance Sales Agreement; To Offer Up To $50M In Common Stock

CACI

CACI International Awarded Nearly $638M In New Contracts Within Intelligence Community To Support National Security Efforts

Financing

Humana Enters Into $5B Unsecured Revolving Credit Agreement; Agreement Permits Up To $1B Of Incremental Commitments; New Agreement Replaces Existing $2.1B Credit Agreement

Color Star Technology Co Louis Luo Resigned From His Position As Ceo; Samantha Huang Appointed As Ceo

SIEB

Siebert Financial Files For Mixed Shelf Of Up To $100M

<ul>
<li>The Generation Essentials Group and Black Spade Acquisition II Co Expect to Close the Business Combination on June 3, 2025.</li>
<li>TGE's Class A Ordinary Shares and Warrants are Expected to Be Listed on the New York Stock Exchange and NYSE American under Ticker Symbols "TGE" and "TGEWS", Respectively, Shortly After the Closing of the Business Combination, on a Date to be Announced.</li>
</ul>
The Generation Essentials Group ("TGE") and Black Spade Acquisition II Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSII#NASDAQ">BSII</a>) ("Black Spade II") today announced that their previously announced business combination (the "Business Combination") was approved at an extraordinary general meeting of Black Spade II's shareholders on May 30, 2025.
Complete official results of the vote will be included in a current report on Form 8-K to be filed by Black Spade II with the U.S. Securities and Exchange Commission.
The Business Combination is expected to close on June 3, 2025. Upon such closing, TGE will remain as the combined company, and its Class A ordinary shares and warrants are expected to be listed on the New York Stock Exchange and NYSE American under the ticker symbols "TGE" and "TGEWS", respectively, shortly thereafter, on a date to be announced.

BSII

Generation Essentials Group And Black Spade Acquisition II Co Set To Close Business Combination On June 3, 2025; TGE Shares To Trade On NYSE Under Ticker Symbol "TGE" Following Closing

DIST

Distoken Acquisition Corp Enters Business Combination Agreement With Youlife Group

Plus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSTV#NASDAQ">PSTV</a>) reported quarterly losses of $(1.19) per share which missed the analyst consensus estimate of $(0.25) by 376 percent. This is a 58.67 percent decrease over losses of $(0.75) per share from the same period last year. The company reported quarterly sales of $1.06 million which missed the analyst consensus estimate of $1.48 million by 28.61 percent. This is a 36.85 percent decrease over sales of $1.68 million the same period last year.

Earnings

Earnings Misses

PSTV

Plus Therapeutics Q1 EPS $(1.19) Misses $(0.25) Estimate, Sales $1.06M Miss $1.48M Estimate

TVRD

Tvardi Therapeutics Files Prospectus Relates To Resale By Selling Stockholders Of Up To 2.1M Shares Of Common Stock

Press Releases

Mobile-health Network Solutions to Present at Two Financial Conferences for October 2024

Mobile-health Network Solutions (Nasdaq: MNDR) Fiscal 2024 Results to be Announced October 23rd, 2024; Conference Call to Discuss Results October 24th at 8:00 AM ET

Mobile-health Network Solutions Reports 77 Percent Revenue Increase for Fiscal Year 2024

Mobile-health Network Solutions to Present at Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference on December 3-4, 2024

Mobile-health Network Solutions Launches ManaSocial, New Digital Healthcare Engagement Platform Expected to Accelerate Growth

Mobile-health Network Solutions Wins Cloud-Healthcare Technology Award at SBR Technology Excellence Awards 2025

Mobile-health Network Solutions Intends To Acquire Lifepack, Expanding into Indonesia's Growing Healthcare Market

Mobile-health Network Solutions to Present at Sidoti Virtual Investor Conference, May 21-22, and Virtual Tech Conference, June 3-5

Mobile-health Network Solutions Signs MOU to Add AI-enabled Dental Scans and Oral Health Screening to its Telemedicine Platform

CORRECTION FROM SOURCE: Mobile-health Network Solutions Signs MOU to Add AI-enabled Dental Scans and Oral Health Screening to its Telemedicine Platform

MNDR

American Shared Hospital Services Common Stock

American Shared Hospital

Biodesix

Basel Medical Group Ltd - ordinary shares

Basel Medical Group

Cryo-Cell International, Inc. Common Stock

Cryo-Cell International

ModivCare

MSP Recovery, Inc. - Class A Common Stock

MSP Recovery

Kindly MD

NewGenIvf Group Limited - Class A Ordinary Shares

NewGenIvf Group

Ontrak

P3 Health Partners Inc. - Class A Common Stock

P3 Health Partners

Prenetics Global Limited - Class A Ordinary Share

Prenetics Global

Precipio

Vivos Therapeutics

Screenshot 2025-03-27 at 6.13.59 PM

Health Care

Mobile-health Network Solutions Aims To Provide Affordable, Fast, Convenient Mobile Health

Comments

Mobile-health Network

空売り

Mobile-health Network (NASDAQ:MNDR) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル